MPO and colitis: Administration of FVP (50 mg/kg and 100 mg/kg) reduced inflammatory response in DSS-induced colitis, significantly inhibited myeloperoxidase (MPO) activity, decreased levels of DAO and NO, and effectively restored the metabolic balance of intestinal microorganisms, especially promoting butyric acid production.